Eckart Bartnik

Sanofi R&D, Sanofi
Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1-mediated chronic inflammatory skin diseases.

Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1-mediated chronic inflammatory skin diseases.

Journal: The Journal of allergy and clinical immunology

Published: July 18, 2025

The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: A potential disease-modifying OA drug.

The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: A potential disease-modifying OA drug.

Journal: Osteoarthritis and cartilage

Published: November 17, 2022

Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.

Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.

Journal: The Journal of allergy and clinical immunology

Published: March 25, 2022

Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.

Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.

Journal: The British journal of dermatology

Published: December 30, 2020

Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.

Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.

Journal: Disease models & mechanisms

Published: August 05, 2020

The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab.

The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab.

Journal: Inflammatory bowel diseases

Published: August 06, 2019

Translational drug discovery and development with the use of tissue-relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy.

Translational drug discovery and development with the use of tissue-relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy.

Journal: Experimental dermatology

Published: June 12, 2018

Determination of serum biomarkers in osteoarthritis patients: a previous interventional imaging study revisited.

Determination of serum biomarkers in osteoarthritis patients: a previous interventional imaging study revisited.

Journal: Journal of biomedical research

Published: August 16, 2017

Sample Size Calculations for Detecting Disease-Modifying Osteoarthritis Drug Effects on Knee Replacement Incidence in Clinical Trials: Data From the Osteoarthritis Initiative.

Sample Size Calculations for Detecting Disease-Modifying Osteoarthritis Drug Effects on Knee Replacement Incidence in Clinical Trials: Data From the Osteoarthritis Initiative.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 06, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026